Preventing congestive heart failure.
The morbidity, mortality and health care costs associated with congestive heart failure make prevention a more attractive public health strategy than treatment. Aggressive management of etiologic factors, including hypertension, coronary artery disease, valvular disease and excessive alcohol intake, can prevent the left ventricular remodeling and dysfunction that lead to heart failure. Early intervention with angiotensin converting enzyme inhibitors in patients with chronic left ventricular dysfunction can prevent, as well as treat, the syndrome. Several intervention strategies in patients with acute myocardial infarction can slow or prevent the left ventricular remodeling process that antedates congestive heart failure. The primary care physician must be alert to the need for aggressive intervention to reduce the burden of heart failure syndrome on the patient and on society.
Cohn
J N
JN
Department of Medicine, University of Minnesota Medical School, Minneapolis, USA.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000150:complications / Q000628:therapy; D003327:Coronary Disease / Q000150:complications / Q000628:therapy; D006333:Heart Failure / Q000209:etiology* / Q000517:prevention & control*; D006349:Heart Valve Diseases / Q000150:complications / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000628:therapy; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors